Aptose Biosciences's total assets for Q1 2025 were $7.47M, a decrease of -26.27% from the previous quarter. APTO total liabilities were $14.86M for the fiscal quarter, a 1.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.